Health officials in South Korea say they will decide whether to resume administrating AstraZeneca's coronavirus vaccines to people 60 and younger over the weekend.
The injections were paused while regulators in Europe reviewed a possible link between the shots and rare blood clots.
Officials say the European Medicine Agency emphasized that the benefits of receiving the AstraZeneca vaccine continue to outweigh the risks for most people, even though it said it had found a possible link between the shot and the rare clots.
South Korea's mass immunization campaign has mainly relied on AstraZeneca shots produced locally.
The country has so far administered first doses to about 1 million people.
Customer Service Hotline: 02-8522-7177 | Email: icrtclub@icrt.com.tw Customer Service Hours: Monday-Friday 10AM-6PM nternational Community Radio Taipei 19-5F, No. 5, Sec. 3, New Taipei Blvd., Xinzhuang Dist., New Taipei City 24250